• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状旁腺病变中 18F-FCH 摄取强度与细胞含量的关系。

The relationship between 18F-FCH uptake intensity and cell content in parathyroid lesions.

机构信息

Department of Nuclear Medicine, Medical Faculty, Ankara University Medical School, Ankara, Turkey.

Department of Pathology, Ankara University Medical School, Ankara, Turkey.

出版信息

Eur Arch Otorhinolaryngol. 2023 Jun;280(6):2905-2910. doi: 10.1007/s00405-023-07870-9. Epub 2023 Feb 15.

DOI:10.1007/s00405-023-07870-9
PMID:36790722
Abstract

PURPOSE

To investigate the relationship between cell content and histopathological features of parathyroid lesions and 18F-FCH uptake intensity on PET/CT images.

METHODS

Patients with primary hyperparathyroidism (age > 18) who were referred to 18F-FCH PET/CT were involved. All patients underwent parathyroidectomy. Correlation of SUVmax with following factors were statistically analysed: serum PTH, Ca, P levels and histopathological parameters, total absolute amounts of chief cell, oxyphyllic cell and clear cell components calculated by the multiplication of the volume of the parathyroid lesion and the percentage of each type of cell content (called as Absolute, Absolute and Absolute reflecting the total amount of each cell group).

RESULTS

A total of 34 samples from 34 patients (6M, 28F, mean age: 53.32 ± 15.15, min: 14, max: 84) who had a positive 18F-FCH PET/CT localizing at least one parathyroid lesion were involved. In the whole study group, SUVmax was found to be correlated with the greatest diameter and volume of the lesion and Absolute (p = 0.004, p = 0.002 and p = 0.035, respectively). In the subgroup analysis of 28 samples with longest diameter > 1 cm, the correlation between SUVmax and Absolute remained significant (p = 0.036) and correlation between SUVmax and volume and longest diameter became stronger (p = 0.011 and p > 0.001, respectively). No correlation was found between SUVmax and Absolute or Absolute.

CONCLUSIONS

There might be a relationship between 18F-FCH uptake intensity and chief cell content in patients with parathyroid adenoma. Further studies with larger patient groups would be beneficial to support the data.

摘要

目的

研究甲状旁腺病变的细胞含量与组织病理学特征以及 PET/CT 图像上 18F-FCH 摄取强度之间的关系。

方法

纳入因原发性甲状旁腺功能亢进(年龄>18 岁)而接受 18F-FCH PET/CT 检查的患者。所有患者均接受甲状旁腺切除术。统计分析 SUVmax 与以下因素的相关性:血清 PTH、Ca、P 水平和组织病理学参数,通过将甲状旁腺病变的体积乘以每种细胞含量的百分比来计算主细胞、嗜酸性细胞和透明细胞成分的总绝对量(称为 Absolute、Absolute 和 Absolute,反映每个细胞群的总含量)。

结果

共纳入 34 例 34 名患者(6 名男性,28 名女性,平均年龄:53.32±15.15 岁,年龄范围 14 岁至 84 岁)的 34 个样本,这些患者的 18F-FCH PET/CT 均显示至少有一个甲状旁腺病变呈阳性定位。在整个研究组中,SUVmax 与病变的最大直径和体积以及 Absolute 呈正相关(p=0.004、p=0.002 和 p=0.035)。在最长直径>1cm 的 28 个样本的亚组分析中,SUVmax 与 Absolute 之间的相关性仍然显著(p=0.036),SUVmax 与体积和最长直径之间的相关性也增强(p=0.011 和 p>0.001)。SUVmax 与 Absolute 或 Absolute 之间无相关性。

结论

在甲状旁腺腺瘤患者中,18F-FCH 摄取强度与主细胞含量之间可能存在一定关系。进一步的大样本量研究将有助于支持这一数据。

相似文献

1
The relationship between 18F-FCH uptake intensity and cell content in parathyroid lesions.甲状旁腺病变中 18F-FCH 摄取强度与细胞含量的关系。
Eur Arch Otorhinolaryngol. 2023 Jun;280(6):2905-2910. doi: 10.1007/s00405-023-07870-9. Epub 2023 Feb 15.
2
[F]Fluorocholine Uptake of Parathyroid Adenoma Is Correlated with Parathyroid Hormone Level.甲状旁腺腺瘤的氟胆碱摄取与甲状旁腺激素水平相关。
Mol Imaging Biol. 2018 Oct;20(5):857-867. doi: 10.1007/s11307-018-1179-x.
3
Performance of F-18 Fluorocholine PET/CT for Detection of Hyperfunctioning Parathyroid Tissue in Patients with Elevated Parathyroid Hormone Levels and Negative or Discrepant Results in conventional Imaging.氟代胆碱 F-18 PET/CT 对甲状旁腺激素水平升高且常规影像学检查阴性或结果不一致的患者异位甲状旁腺组织的探测效能。
Korean J Radiol. 2020 Feb;21(2):236-247. doi: 10.3348/kjr.2019.0268.
4
F-choline PET/4D CT in hyperparathyroidism: correlation between biochemical data and study parameters.F-胆碱 PET/4D CT 在甲状旁腺功能亢进症中的应用:生化数据与研究参数的相关性。
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Sep-Oct;39(5):273-278. doi: 10.1016/j.remn.2020.03.017. Epub 2020 Jun 12.
5
The efficacy of fluorine-18-choline PET/CT in comparison with 99mTc-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism.18F-胆碱PET/CT与99mTc-MIBI SPECT/CT在原发性甲状旁腺功能亢进症中高功能甲状旁腺定位方面的疗效比较。
Nucl Med Commun. 2018 Nov;39(11):989-994. doi: 10.1097/MNM.0000000000000899.
6
Added value of 18F-fluorocholine positron emission tomography-computed tomography in presurgical localization of hyperfunctioning parathyroid glands after dual tracer subtraction scintigraphy failure: A retrospective study of 47 patients.双示踪剂减影闪烁扫描失败后,18F-氟胆碱正电子发射断层扫描-计算机断层扫描在功能亢进甲状旁腺术前定位中的附加价值:47例患者的回顾性研究
Medicine (Baltimore). 2020 Jan;99(2):e18681. doi: 10.1097/MD.0000000000018681.
7
Dual-Time-Point F-Fluorocholine PET/CT in Parathyroid Imaging.双时相 F-氟代胆碱 PET/CT 在甲状旁腺成像中的应用。
J Nucl Med. 2019 Nov;60(11):1605-1610. doi: 10.2967/jnumed.118.225599. Epub 2019 Mar 15.
8
The utility of 18F-fluorocholine PET/CT in the imaging of parathyroid adenomas.18F-氟胆碱 PET/CT 在甲状旁腺腺瘤成像中的应用。
Endokrynol Pol. 2022;73(1):43-48. doi: 10.5603/EP.a2021.0107. Epub 2022 Feb 4.
9
Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism?18F-氟胆碱正电子发射断层扫描/计算机断层扫描是否为原发性或继发性甲状旁腺功能亢进症中检测功能亢进甲状旁腺的新成像工具?
J Clin Endocrinol Metab. 2014 Dec;99(12):4531-6. doi: 10.1210/jc.2014-2821.
10
Misleading localization by F-fluorocholine PET/CT in familial hypocalciuric hypercalcemia type-3: a case report.F-氟胆碱 PET/CT 在外源性家族性低钙血症高钙血症 3 型中的定位错误:1 例报告。
BMC Endocr Disord. 2021 Jan 26;21(1):20. doi: 10.1186/s12902-021-00683-z.

本文引用的文献

1
Histopathological Features of Parathyroid Adenoma and 18F-Choline Uptake in PET/MR of Primary Hyperparathyroidism.原发性甲状旁腺功能亢进症中甲状旁腺腺瘤的组织病理学特征及 18F-胆碱摄取的 PET/MR 表现
Clin Nucl Med. 2022 Feb 1;47(2):101-107. doi: 10.1097/RLU.0000000000003987.
2
F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature.F-胆碱 PET/CT 和 PET/MRI 在原发性和复发性甲状旁腺功能亢进症中的应用:文献系统评价。
Ann Nucl Med. 2020 Sep;34(9):601-619. doi: 10.1007/s12149-020-01507-1. Epub 2020 Aug 7.
3
MIBI scintigraphy of parathyroid adenomas: correlation with biochemical and histological markers.
Endocr Res. 2018 Aug;43(3):141-148. doi: 10.1080/07435800.2018.1437747. Epub 2018 Feb 20.
4
Optimal scan time for evaluation of parathyroid adenoma with [(18)F]-fluorocholine PET/CT.使用[(18)F] - 氟胆碱PET/CT评估甲状旁腺腺瘤的最佳扫描时间。
Radiol Oncol. 2015 Nov 27;49(4):327-33. doi: 10.1515/raon-2015-0016. eCollection 2015 Dec.
5
Parathyroid scintigraphy in patients with primary hyperparathyroidism: 99mTc sestamibi SPECT and SPECT/CT.原发性甲状旁腺功能亢进患者的甲状旁腺闪烁扫描:99mTc 甲氧基异丁基异腈单光子发射计算机断层扫描(SPECT)及 SPECT/CT
Radiographics. 2008 Sep-Oct;28(5):1461-76. doi: 10.1148/rg.285075055.
6
(18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.(18)肿瘤学中F标记的正电子发射断层显像放射性药物:放射化学与肿瘤定位机制概述
Semin Nucl Med. 2007 Nov;37(6):400-19. doi: 10.1053/j.semnuclmed.2007.08.004.
7
Partial-volume effect in PET tumor imaging.PET肿瘤成像中的部分容积效应。
J Nucl Med. 2007 Jun;48(6):932-45. doi: 10.2967/jnumed.106.035774. Epub 2007 May 15.
8
A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003.1995年至2003年原发性甲状旁腺功能亢进症诊断与治疗的系统评价
Otolaryngol Head Neck Surg. 2005 Mar;132(3):359-72. doi: 10.1016/j.otohns.2004.10.005.
9
Understanding the standardized uptake value, its methods, and implications for usage.了解标准化摄取值、其测量方法及其使用的意义。
J Nucl Med. 2004 Sep;45(9):1431-4.
10
Reproducibility of common semi-quantitative parameters for evaluating lung cancer glucose metabolism with positron emission tomography using 2-deoxy-2-[18F]fluoro-D-glucose.使用2-脱氧-2-[¹⁸F]氟-D-葡萄糖正电子发射断层扫描评估肺癌葡萄糖代谢的常见半定量参数的可重复性。
Mol Imaging Biol. 2002 Mar;4(2):171-8. doi: 10.1016/s1536-1632(01)00004-x.